BOSTON–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Firm”), a wearable medical robotics firm that provides elevated performance for these affected by neurological issues and upper-limb paralysis, right now introduced monetary outcomes for the three and 9 months ended September 30, 2024. Monetary and working highlights for the third quarter of 2024 embrace the next (all comparisons are with the third quarter of 2023 except in any other case indicated): Product a
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/myomo-reports-record-third-quarter-financial-and-operating-results/
